Instituto Universitario de Investigación en Neuroquímica
Centro/Instituto
Hebrew University of Jerusalem
Jerusalén, IsraelPublicacións en colaboración con investigadores/as de Hebrew University of Jerusalem (15)
2021
-
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1
Autophagy, Vol. 17, Núm. 1, pp. 1-382
2016
2013
-
Cannabidiol for neurodegenerative disorders: Important new clinical applications for this phytocannabinoid?
British Journal of Clinical Pharmacology, Vol. 75, Núm. 2, pp. 323-333
-
Motor effects of the non-psychotropic phytocannabinoid cannabidiol that are mediated by 5-HT1A receptors
Neuropharmacology, Vol. 75, pp. 155-163
2012
-
Guidelines for the use and interpretation of assays for monitoring autophagy
Autophagy, Vol. 8, Núm. 4, pp. 445-544
2011
-
Prospects for cannabinoid therapies in basal ganglia disorders
British Journal of Pharmacology, Vol. 163, Núm. 7, pp. 1365-1378
2009
-
Cannabinoid CB2 receptor agonists protect the striatum against malonate toxicity: Relevance for Huntington's disease
GLIA, Vol. 57, Núm. 11, pp. 1154-1167
2008
-
The CB2 cannabinoid receptor controls myeloid progenitor trafficking: Involvement in the pathogenesis of an animal model of multiple sclerosis
Journal of Biological Chemistry, Vol. 283, Núm. 19, pp. 13320-13324
2007
-
Cannabidiol reduced the striatal atrophy caused 3-nitropropionic acid in vivo by mechanisms independent of the activation of cannabinoid, vanilloid TRPV1 and adenosine A2A receptors
European Journal of Neuroscience, Vol. 26, Núm. 4, pp. 843-851
-
Cannabinoids induce glioma stem-like cell differentiation and inhibit gliomagenesis
Journal of Biological Chemistry, Vol. 282, Núm. 9, pp. 6854-6862
-
Evaluation of the neuroprotective effect of cannabinoids in a rat model of Parkinson's disease: Importance of antioxidant and cannabinoid receptor-independent properties
Brain Research, Vol. 1134, Núm. 1, pp. 162-170
2006
-
A cannabinoid quinone inhibits angiogenesis by targeting vascular endothelial cells
Molecular Pharmacology, Vol. 70, Núm. 1, pp. 51-59
-
Non-psychoactive CB2 cannabinoid agonists stimulate neural progenitor proliferation
FASEB Journal, Vol. 20, Núm. 13
2005
-
Cannabinoids provide neuroprotection against 6-hydroxydopamine toxicity in vivo and in vitro: Relevance to Parkinson's disease
Neurobiology of Disease, Vol. 19, Núm. 1-2, pp. 96-107